Source: BioPortfolio

Tetragenetics: TetraGenetics Appoints Alison TauntonRigby Ellen Baron and Daniel Grau to its Board of Directors

Biopharma and Investment Executives with Deep Industry Experience to Support Continued Growth of TetraGenetics Ion Channel Pipeline and Platform TetraGenetics a biopharmaceutical company developing novel antibody therapeuti...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Douglas R. Kahn's photo - Chairman & CEO of Tetragenetics

Chairman & CEO

Douglas R. Kahn

CEO Approval Rating

87/100

Read more